The possible clinical impact of risperidone on P‐glycoprotein‐mediated transport of tacrolimus: A case report and in vitro study

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-081x|39|1|30-37

ISSN： 0142-2782

Source： Biopharmaceutics And Drug Disposition, Vol.39, Iss.1, 2018-01, pp. : 30-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural Determinants of P-Glycoprotein-Mediated Transport of Glucocorticoids

By Yates Charles R.   Chang Cheng   Kearbey Jeffrey D.   Yasuda Kazuto   Schuetz Erin G.   Miller Duane D.   Dalton James T.   Swaan Peter W.  

Pharmaceutical Research, Vol. 20, Iss. 11, 2003-11 ,pp. : 1794-1803

Springer Publishing Company

Access to resources Recommend Favorite

Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

By Woodland Cindy   Koren Gideon   Wainer Irving W   Batist Gerry   Ito Shinya  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 8, 2003-08 ,pp. : 800-805

NRC Research Press

Access to resources Recommend Favorite

Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles

By  

Current Pharmaceutical Design, Vol. 19, Iss. 37, 2013-11 ,pp. : 6655-6666

Bentham Science Publishers

Access to resources Recommend Favorite

Reversible neutropenia during a cold: possible involvement of risperidone? A case report

By Meylan C.   Bondolfi G.   Aubert A.-C.   Baumann P.  

European Neuropsychopharmacology, Vol. 5, Iss. 1, 1995-03 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Amlodipine/tacrolimus interaction: Acute renal failure in a patient with diarrhoea, CYP3A5 deficiency and decreased P-gp transport activity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite